Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.
Publication
, Journal Article
Williams, CD; Grady, WM; Zullig, LL
Published in: J Natl Compr Canc Netw
November 2016
Colorectal cancer (CRC) remains a common cancer and significant public health burden. CRC-related mortality is declining, partly due to the early detection of CRC through robust screening. NCCN has established the NCCN Guidelines for CRC Screening to help healthcare providers make appropriate screening recommendations according to the patient's risk of developing CRC. This review describes the evolution of CRC screening guidelines for average-risk individuals, discusses the role of NCCN Guidelines for CRC Screening in cancer prevention, and comments on the current and emerging use of biomarkers for CRC screening.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
November 2016
Volume
14
Issue
11
Start / End Page
1479 / 1485
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Mass Screening
- Humans
- Early Detection of Cancer
- Colorectal Neoplasms
- Biomarkers, Tumor
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Williams, C. D., Grady, W. M., & Zullig, L. L. (2016). Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening. J Natl Compr Canc Netw, 14(11), 1479–1485. https://doi.org/10.6004/jnccn.2016.0154
Williams, Christina D., William M. Grady, and Leah L. Zullig. “Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.” J Natl Compr Canc Netw 14, no. 11 (November 2016): 1479–85. https://doi.org/10.6004/jnccn.2016.0154.
Williams CD, Grady WM, Zullig LL. Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening. J Natl Compr Canc Netw. 2016 Nov;14(11):1479–85.
Williams, Christina D., et al. “Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.” J Natl Compr Canc Netw, vol. 14, no. 11, Nov. 2016, pp. 1479–85. Pubmed, doi:10.6004/jnccn.2016.0154.
Williams CD, Grady WM, Zullig LL. Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening. J Natl Compr Canc Netw. 2016 Nov;14(11):1479–1485.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
November 2016
Volume
14
Issue
11
Start / End Page
1479 / 1485
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Mass Screening
- Humans
- Early Detection of Cancer
- Colorectal Neoplasms
- Biomarkers, Tumor
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis